Discontinuation report BUSULFEX
| Report ID | 120940 |
| Drug Identification Number | 02240602 |
| Brand name | BUSULFEX |
| Common or Proper name | busulfex |
| Company Name | OTSUKA PHARMACEUTICAL CO LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUSULFAN |
| Strength(s) | 60MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 6mg/mL, 10 mL vial |
| ATC code | L01AB |
| ATC description | ALKYLATINGAGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-09-01 |
| Actual discontinuation date | 2020-09-01 |
| Remaining supply date | 2020-10-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2-9 KANDA-TSUKASAMACHI CHIYODA-KU TOKYO, -- JAPAN 101-8535 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-09-02 | English | Compare |
| v5 | 2020-07-23 | French | Compare |
| v4 | 2020-07-23 | English | Compare |
| v3 | 2020-07-23 | French | Compare |
| v2 | 2020-07-23 | English | Compare |
| v1 | 2020-07-23 | English | Compare |
Showing 1 to 6 of 6